Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | RARB | P10826 | 6/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | RARA | P10276 | 1/20 | 0.51 |
| ▸ | MTOR | P42345 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 4/20 | 0.49 |
| ▸ | THRA | P10827 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11547790 | 1.00 | MAPT (0.55) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 | |
| SCHEMBL20594587 | 1.00 | MAPT (0.55) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 | |
| SCHEMBL20594622 | 0.99 | MAPT (0.54) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 | |
| SCHEMBL9434739 | 0.99 | MAPT (0.54) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 | |
| SCHEMBL10746703 | 0.99 | MAPT (0.54) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 | |
| SCHEMBL29359854 | 0.99 | MAPT (0.54) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 | |
| SCHEMBL9185134 | 0.99 | MAPT (0.54) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 | |
| SCHEMBL20594559 | 0.99 | MAPT (0.54) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 | |
| SCHEMBL5065172 | 0.99 | MAPT (0.54) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 | |
| SCHEMBL8955924 | 0.96 | RARB (0.51) | MAPTSMN1; SMN2RARBMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 608 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11299675-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2022-04-12 | — | — | US | disclosed |
| US-11193066-B2 | Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display device and use thereof | JNC CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| US-10975305-B2 | Piperidine derivative, liquid crystal composition, and liquid crystal display element | JNC CORPORATION (JP) | 2021-04-13 | — | — | US | disclosed |
| US-20210071080-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2021-03-11 | — | — | US | disclosed |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | JNC CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| US-20200299578-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2020-09-24 | — | — | US | disclosed |
| US-10759998-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display element | JNC CORPORATION (JP) | 2020-09-01 | — | — | US | disclosed |
| EP-3305774-B1 | BENZOTHIOPHENE-CONTAINING LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2020-08-26 | — | — | EP | disclosed |
| US-20200263089-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2020-08-20 | — | — | US | disclosed |
| US-20200239775-A1 | TETRACYCLIC LIQUID CRYSTAL COMPOUND HAVING DIATOMIC BONDING GROUP AND 2,3-DIFLUOROPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2020-07-30 | — | — | US | disclosed |
| US-20070187644-A1 | Liquid crystal compound, liquid crystal composition, and liquid crystal display device | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2007-08-16 | — | — | US | disclosed |
| EP-1818384-A1 | Liquid crystal compound, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2007-08-15 | — | — | EP | disclosed |
| US-7247355-B2 | Liquid crystal compound having chroman ring, liquid crystal composition comprising the compound and liquid crystal display device comprising the composition | CHISSO CORPORATION (JP) | 2007-07-24 | — | — | US | disclosed |
| US-7247355-B2 | Liquid crystal compound having chroman ring, liquid crystal composition comprising the compound and liquid crystal display device comprising the composition | CHISSO CORPORATION (JP) | 2007-07-24 | — | — | US | disclosed |
| EP-1798228-A1 | TETRAHYDROPYRAN COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS, AND LIQUID CRYSTAL DISPLAYS CONTAINING THE COMPOSITIONS | CHISSO CORPORATION (JP) | 2007-06-20 | — | — | EP | disclosed |
| US-20070108410-A1 | Liquid crystal compound having lactone ring, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION | 2007-05-17 | — | — | US | disclosed |
| US-20070108410-A1 | Liquid crystal compound having lactone ring, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION | 2007-05-17 | — | — | US | disclosed |
| EP-1762605-A1 | Naphthalene compound with terminal hydrogen, liquid crystal composition including the compound, and LCD device including the liquid crystal composition | Chisso Petrochemial Corporation (JP) | 2007-03-14 | — | — | EP | disclosed |
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | LEF1, CFD, FOXO1 | MAPT 3479/4885SMN1; SMN2 2411/4885RARB 4017/4885 |
| US-11193066-B2 | Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display device and use thereof | OCIAD2, PYM1, C1S | MAPT 1096/4885SMN1; SMN2 2325/4885RARB 2346/4885 |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | ACP1, MAPK1, PLD1 | MAPT 1536/4885SMN1; SMN2 3758/4885RARB 3543/4885 |
| US-20070108410-A1 | Liquid crystal compound having lactone ring, liquid crystal composition, and liquid crystal display device | TCF7L2, TCF7, CA7 | MAPT 3573/4885SMN1; SMN2 4751/4885RARB 245/4885 |
| US-10759998-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display element | SP1, SFXN3, SFXN1 | MAPT 1879/4885SMN1; SMN2 2234/4885RARB 3235/4885 |
| US-20200299578-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, CCND1, CPNE4 | MAPT 2337/4885SMN1; SMN2 3491/4885RARB 3668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.